TwentyTwo
AI infrastructure for biosecurity
TwentyTwo is active in the healthcare space based in New York, NY, USA, founded in 2013.
Profile
AI is making biology easy to engineer. Life-saving drugs and therapies are accelerating, but so is the ability for bad actors to create a pandemic. TwentyTwo is working on the defensive stack to prevent the next pandemic.
As a business in healthcare, TwentyTwo is listed here with the public details available about it.
The company is recorded as being based in New York, NY, USA.
Directory data places it at the Summer 2025 stage.
Recorded headcount: 3 employees.
Directory analysis
TwentyTwo develops AI‑driven infrastructure to strengthen biosecurity, providing defensive tools that detect and mitigate risks arising from rapid biotechnological advances. The company focuses on preventing the misuse of biology that could lead to pandemics, positioning itself at the intersection of AI and public health safety. Founded in 2013 and headquartered in New York, it serves the healthcare and biosecurity sectors.
Positioning: TwentyTwo occupies a niche at the convergence of AI and biosecurity, offering defensive solutions that complement existing public health safeguards. Its success will hinge on regulatory acceptance and the ability to integrate with national and international biosecurity frameworks.
Note: TwentyTwo specializes in AI‑based tools designed to prevent bioterrorism and pandemic risks.
Auto-generated directory analysis from public data · updated 9 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | New York, NY, USA |
| Country | USA |
| Founded | 2013 |
| Employees | 3 |
| Stage | Summer 2025 |
Website: twentytwo.bio
Browse related
Create a free account